Global Intranasal Drug Delivery Devices Market
The
Global Intranasal
Drug Delivery Devices Market size was valued at USD 46.68
billion in 2019 and is projected to expand at a CAGR of 6.7% over the forecast
period to reach the valuation of USD 78.43 billion by 2027. Increasing
preference for an alternative mode of drug administration is one of the major
factors expected to fuel market growth during the forecast period. The growing
incidence of chronic diseases is also expected to contribute to intranasal drug
delivery devices market expansion over the coming years.
According
to a study published in Research and Development (RAND) Review blog in 2017,
around 60% of American adults have at least one chronic condition, which
results in huge spending on healthcare every year. Additionally, nearly 30
million Americans live with five chronic conditions or more. Moreover, the
commercialization of innovative products and the presence of a robust product
pipeline are anticipated to boost the intranasal drug delivery devices market
growth.
The
report is furnished with the latest market scenario pertaining to the COVID-19
pandemic and its after-effects on the Intranasal Drug Delivery Devices industry
and the key segments. The pandemic has disrupted the workflow of the industry
and created financial difficulties. The report assesses the complete impact of
the pandemic on the market and offers key insights into the market scenario
along with trends and demands disruptions. The report also offers an outlook on
the market scenario in the forecast timeline.
Get a sample of the report @ https://www.reportsanddata.com/toc-form/3570
Some
of the players profiled in the report are GlaxoSmithKline
PLC; AstraZeneca PLC; Pfizer, Inc.; OptiNose, Inc.; Becton, Dickinson and
Company; Promius Pharma, LLC; Cadila Pharmaceuticals Ltd.; B.F. Ascher &
Company, Inc.; PendoPharm, Inc.; Douglas Pharmaceuticals Ltd.; ENT Technologies
Pty. Ltd.; and NAVEH Pharma Ltd.
The Global Intranasal Drug Delivery Devices Market is
segmented as follows:
By Dosage Form (Revenue, USD Billion, 2017 - 2027)
Spray
Drops
Gel
Powder
By Container Type (Revenue, USD Billion, 2017 - 2027)
Pressurized
Non-pressurized
By Therapeutic Application (Revenue, USD Billion, 2017
- 2027)
Nasal
Congestion
Rhinitis
Asthma
Others
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3570
Market Segmentation by Regions:
North America (U.S.,
Canada)
Europe (U.K., Italy,
Germany, France, Rest of EU)
Asia Pacific (India,
Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile,
Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi
Arabia, U.A.E., South Africa, Rest of MEA)
Key Questions
Answered by the Report:
·
Which market segment
or sub-segment is expected to grow at the highest CAGR during the forecast
timeline?
·
What is the forecast
valuation of the Intranasal Drug Delivery Devices market?
·
Who are the leading
players in the industry? What are the weaknesses and strengths of these players?
·
What are the strategic
business steps and initiatives taken by the key competitors in the industry?
·
What region is
expected to dominate the market in the forecast period?
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/intranasal-drug-delivery-devices-market
Thank
you for reading the report. The report can be customized as per the requirements
of the clients. For further information or queries about customization options,
please reach out to us, and we will offer you the report best suited for your
needs.
Contact
Us:
John
Watson
Head
of Business Development
Direct
Line: +1-212-710-1370
E-mail:
sales@reportsanddata.com
No comments:
Post a Comment